Sign in
Canada Source-linked decisions Coverage checked

Canada Case Law

Search judgments by proposition, citation, court, judge or legal topic, then move directly into the source-grounded case analysis.

Courts on this page
2 court collections
Last checked

Canada decisions

Decisions matching the current search

Clear filters
Intellectual property 2026 FCA 71

McCain Foods Limited v. J.R. Simplot Company

The Federal Court did not commit a palpable and overriding error in its factual appreciation of expert evidence and common general knowledge; 'high electric field' in Claim 1 is properly understood by a skilled person at the date of publication to refer to electric fields in the range of about 2 to 200 V/cm, which excludes Simplot's pulsed electric field systems, and the appeal is dismissed.

  • Claim construction
  • Infringement
  • Invalidity
  • Utility
  • Person skilled in the art
  • Standard of review
Read case analysis
Patent law 2026 FCA 59

Proslide Technology Inc. v. Whitewater West Industries, LTD.

The Court allowed the appeal in part, concluding the Federal Court erred in finding asserted claims invalid for overbreadth by privileging pre-filing inventor testimony and expert perspectives over the patent specification; the specification controls the assessment of what the inventor contemplated at the filing date. The Court affirmed the Federal Court's conclusion that WhiteWater did not infringe because making/using a claimed physical invention for purposes of s.42 requires physical manufacture/assembly/use in Canada (conceptual designs and advanced design activities in Canada are insuffi…

  • Overbreadth (overclaiming)
  • Patent infringement territoriality
  • Utility and sound prediction
  • Claim construction
  • Remedies and costs
Read case analysis
Patent law 2026 FCA 13

Advanced Powders & Coatings Inc. v. Tekna Plasma Systems Inc.

The Federal Court did not err: the claims were ambiguous because a skilled reader could not reliably distinguish the claimed 'depletion layer' from the native oxide layer (502 Patent) nor determine the existence or parameters of a depletion layer (236 Patent); therefore the claims failed the distinctness/notice requirement and are invalid for ambiguity, and the appeal is dismissed.

  • Claim construction
  • Ambiguity (patent indefiniteness)
  • Invalidity
  • Infringement
  • Insufficiency
  • Costs
Read case analysis
Intellectual property 2025 FCA 214

AGI Suretrack, LLC v. Farmers Edge Inc.

The Court declined to adopt the respondent’s proposed percentage-of-actual-fees approach on appeal, finding that elevated awards tied to actual fees are not routinely appropriate in the appellate context; the respondent did not prove its offers engaged Rule 420 because they lacked an ingredient of compromise; consequently the Court awarded a modest premium over Tariff B Column V, fixing costs at $25,000 plus interest and referring disbursements to the Assessment Officer.

  • Costs
  • Settlement offers
  • Post-judgment interest
  • Claim construction
  • Tariff application
Read case analysis
Patent law 2025 FC 1725

Adeia Guides Inc. v. Videotron Ltd.

The Federal Court considered patent validity, claim construction, infringement, and remedies in a dispute between Adeia Guides Inc. and Videotron Ltd. over interactive television technologies.

  • Infringement
  • Validity
  • Claim construction
  • Anticipation
  • Obviousness
  • Double patenting
Read case analysis
Patent law 2025 FCA 187

NCS Multistage Inc. v. Kobold Corporation

The Federal Court erred in law by misapplying claim differentiation and treating dependent-claim limitations (the sealed embodiment) as excluded from the broader claims; properly construed, claims 6, 11, 12 and 16 of the 571 patent encompass both the sealed and gap embodiments; because claim construction was legally incorrect the question of obviousness double patenting in view of claim 17 of the 830 patent must be remitted to the Federal Court for re-determination; the trial judge's lump sum costs award of $1,800,000 was procedurally and evidentially flawed and is set aside and replaced with…

  • Claim construction
  • Obviousness double patenting
  • Infringement
  • Lump sum costs
  • Procedural fairness
Read case analysis
Intellectual property 2025 FCA 134

AGI Suretrack, LLC v. Farmers Edge Inc.

The Court affirmed the Federal Court’s purposive construction limiting 'manufacturer code' and 'device class' to their ISO meanings, found those parameters and the microprocessor location to be essential based on the disclosure and lack of contrary expert evidence, held the CanPlug and FarmCommand did not include the essential ISO parameters so did not infringe, and concluded the '742 Patent is invalid because the GreenStar 3 anticipated the device claims and the remaining device and system claims were obvious in light of ISO and the common general knowledge; accordingly the appeals were dism…

  • Infringement
  • Anticipation
  • Obviousness
  • Claim construction
  • Essentiality
  • Costs
Read case analysis
Patent law 2025 FC 1078

McCain Foods Limited v. J.R. Simplot Company

The Federal Court construed key patent terms in McCain’s potato-processing patent, found Simplot’s PEF process outside the claims, and dismissed the action.

  • Claim construction
  • Infringement
  • Patent validity
  • Overbreadth
  • Utility (sound prediction)
  • Anticipation
Read case analysis
Patent law 2024 FCA 212

Steelhead LNG (ASLNG) Ltd. v. ARC Resources Ltd.

The Federal Court’s factual findings and credibility assessments supported its conclusions that the asserted claims were disclosed, anticipated or rendered obvious by the prior art; the appellants failed to show any palpable and overriding error or legal error in the Federal Court’s application of disclosure, anticipation and obviousness law, therefore the appeal is dismissed.

  • Anticipation
  • Obviousness
  • Disclosure/enablement
  • Claim construction
  • Standard of review
  • Costs
Read case analysis
Intellectual property 2024 FC 1849

Bayer Inc. v. Amgen Canada Inc.

The Federal Court held that the 276 Patent was ineligible for listing because Claim 58 did not claim the very change in use approved by the SNDS-related NOC.

  • Pmnoc regulations
  • Patent listing eligibility
  • Claim construction
  • Abbott test
  • Notice of compliance
  • Biosimilar regulatory stay
Read case analysis

About this LexChat collection

Canada decisions are organised by court, judge, legal area and indexed issue so a practitioner can move from a proposition to a citable authority with the surrounding context intact.